Diamond Hill Capital Management Inc Laboratory Corp Of America Holdings Transaction History

Diamond Hill Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$209.01 - $232.56 $27.3 Million - $30.4 Million	130,583 Added 9.17%	1,554,443 $340 Million
Q4 2023 Feb 05, 2024	BUY	$197.69 - $227.29 $28.3 Million - $32.5 Million	142,976 Added 11.16%	1,423,860 $324 Million
Q3 2023 Nov 02, 2023	BUY	$201.05 - $221.7 $223 Million - $246 Million	1,108,776 Added 644.23%	1,280,884 $258 Million
Q2 2023 Aug 08, 2023	BUY	$211.93 - $241.33 $36.5 Million - $41.5 Million	172,108 New	172,108 $41.5 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Diamond Hill Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Diamond Hill Capital Management Inc with notifications on news.